Area of injury | Score | Erythropoietin (n=20) | Placebo (n=13) |
Basal ganglia and thalami injury (BGT) | |||
Normal (0) | 8 (40.0%) | 6 (46.2%) | |
Mild (1) | 7 (35.0%) | 2 (15.4%) | |
Moderate (2) | 1 (5%) | 5 (38.5%) | |
Severe (3) | 4 (20.0%) | 0 | |
Posterior limb of internal capsule (PLIC) | |||
Normal (0) | 9 (45%) | 4 (30.8%) | |
Equivocal (1) | 5 (25.0%) | 3 (23.1%) | |
Abnormal (2) | 6 (30.0%) | 6 (46.2%) | |
White matter (WM) | |||
Normal (0) | 4 (20.0%) | 1 (7.7%) | |
Mild (1) | 2 (10%) | 1 (7.7%) | |
Moderate (2) | 10 (50%) | 10 (76.9%) | |
Severe (3) | 4 (20.0%) | 1 (7.7%) | |
Cortex | |||
Normal (0) | 9 (45.0%) | 9 (69.2%) | |
Mild (1) | 5 (25.0%) | 2 (15.4%) | |
Moderate (2) | 1 (5%) | 0 | |
Severe (3) | 5 (25%) | 2 (15.4%) | |
Any area | |||
BGT >0 or PLIC >0 or WM >1 or cortex >1 | 18 (90%) | 12 (92.3%) | |
Cerebral bleeds | 2 (10%) | 0 | |
Sinus venous thrombosis | 2 (10%) | 0 |
No significant difference was noted between brain injury scores in erythropoietin and placebo groups.